364 related articles for article (PubMed ID: 28980272)
1. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.
Alonso N; Moliner P; Mauricio D
Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272
[TBL] [Abstract][Full Text] [Related]
2. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
Seferović PM; Paulus WJ
Eur Heart J; 2015 Jul; 36(27):1718-27, 1727a-1727c. PubMed ID: 25888006
[TBL] [Abstract][Full Text] [Related]
3. Diabetic cardiomyopathy--fact or fiction?
Maisch B; Alter P; Pankuweit S
Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
[TBL] [Abstract][Full Text] [Related]
5. Diabetic cardiomyopathy: factual or factoid?
Quinaglia T; Oliveira DC; Matos-Souza JR; Sposito AC
Rev Assoc Med Bras (1992); 2019 Jan; 65(1):61-69. PubMed ID: 30758422
[TBL] [Abstract][Full Text] [Related]
6. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
[TBL] [Abstract][Full Text] [Related]
8. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
Marwick TH; Ritchie R; Shaw JE; Kaye D
J Am Coll Cardiol; 2018 Jan; 71(3):339-351. PubMed ID: 29348027
[TBL] [Abstract][Full Text] [Related]
9. Diabetic cardiomyopathy: where we are and where we are going.
Lee WS; Kim J
Korean J Intern Med; 2017 May; 32(3):404-421. PubMed ID: 28415836
[TBL] [Abstract][Full Text] [Related]
10. Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity.
Komici K; Femminella GD; de Lucia C; Cannavo A; Bencivenga L; Corbi G; Leosco D; Ferrara N; Rengo G
Aging Clin Exp Res; 2019 Mar; 31(3):321-330. PubMed ID: 29858985
[TBL] [Abstract][Full Text] [Related]
11. Heart Failure in Type 2 Diabetes Mellitus.
Kenny HC; Abel ED
Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
[TBL] [Abstract][Full Text] [Related]
12. Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.
Nandi SS; Mishra PK
Adv Exp Med Biol; 2018; 1056():47-59. PubMed ID: 29754174
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
[TBL] [Abstract][Full Text] [Related]
14. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
[TBL] [Abstract][Full Text] [Related]
15. The diabetic cardiomyopathy.
Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.
Dei Cas A; Spigoni V; Ridolfi V; Metra M
Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):38-50. PubMed ID: 23369136
[TBL] [Abstract][Full Text] [Related]
17. Heart Failure and Diabetes: Perspective of a Dangerous Association.
Favaloro LE; Ratto RD; Musso C
Curr Hypertens Rev; 2021; 17(2):85-93. PubMed ID: 33823781
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
[TBL] [Abstract][Full Text] [Related]
19. Diabetic cardiomyopathy: a brief summary on lipid toxicity.
Ke J; Pan J; Lin H; Gu J
ESC Heart Fail; 2023 Apr; 10(2):776-790. PubMed ID: 36369594
[TBL] [Abstract][Full Text] [Related]
20. Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.
Paolillo S; Marsico F; Prastaro M; Renga F; Esposito L; De Martino F; Di Napoli P; Esposito I; Ambrosio A; Ianniruberto M; Mennella R; Paolillo R; Gargiulo P
Heart Fail Clin; 2019 Jul; 15(3):341-347. PubMed ID: 31079692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
